Greenstone Recalls Methylprednisolone Tablets Due to Dosing Error
Greenstone LLC recalled 3,456 cartons of methylprednisolone tablets on January 15, 2026. The recall follows reports of incorrect dosing information due to misapplied blister foil. Consumers should stop using the product immediately and contact their healthcare provider.
About This Product
Methylprednisolone tablets are corticosteroids used to treat a variety of conditions such as inflammation, allergies, and autoimmune disorders. Patients typically receive these medications through a prescription from healthcare providers.
Why This Is Dangerous
The hazard arises from the incorrect orientation of the blister foil, which misleads users about the correct dosage. This can lead to patients taking more or less medication than prescribed, impacting their treatment.
Industry Context
This recall is not part of a broader industry pattern.
Real-World Impact
Consumers may face health risks if they continue using the affected product. The recall requires immediate action to prevent potential health issues linked to incorrect dosage.